NDC 0078-0876
TobraDex
Tobramycin And Dexamethasone
TobraDex is a Ophthalmic Ointment in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Dexamethasone; Tobramycin.
| Product ID | 0078-0876_38e160ce-912e-4457-a294-2a6a4bf4a068 |
| NDC | 0078-0876 |
| Product Type | Human Prescription Drug |
| Proprietary Name | TobraDex |
| Generic Name | Tobramycin And Dexamethasone |
| Dosage Form | Ointment |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 1988-10-15 |
| Marketing Category | NDA / NDA |
| Application Number | NDA050616 |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | DEXAMETHASONE; TOBRAMYCIN |
| Active Ingredient Strength | 1 mg/g; mg/g |
| Pharm Classes | Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
Packaging
NDC 0078-0876-01
3.5 g in 1 TUBE (0078-0876-01)
| Marketing Start Date | 2020-10-27 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Drug Details
NDC Crossover Matching brand name "TobraDex" or generic name "Tobramycin And Dexamethasone"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0065-0647 | TobraDex | tobramycin and dexamethasone |
| 0065-0648 | TobraDex | tobramycin and dexamethasone |
| 0078-0876 | TobraDex | tobramycin and dexamethasone |
| 0078-0953 | TobraDex | tobramycin and dexamethasone |
| 21695-203 | TobraDex | tobramycin and dexamethasone |
| 21695-628 | TobraDex | tobramycin and dexamethasone |
| 0574-4031 | TOBRAMYCIN AND DEXAMETHASONE | tobramycin and dexamethasone |
| 21695-416 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
| 24208-295 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
| 50090-1135 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
| 50090-1893 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
| 50090-1914 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
| 52959-984 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
| 55700-915 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
| 61314-647 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
| 63629-9570 | TOBRAMYCIN AND DEXAMETHASONE | tobramycin and dexamethasone |
| 63629-9571 | TOBRAMYCIN AND DEXAMETHASONE | tobramycin and dexamethasone |
| 63629-9572 | TOBRAMYCIN AND DEXAMETHASONE | tobramycin and dexamethasone |
| 68071-1655 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
| 68071-1821 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
| 68071-2418 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
| 68071-2772 | TOBRAMYCIN AND DEXAMETHASONE | tobramycin and dexamethasone |
| 68071-4203 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
Trademark Results [TobraDex]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 TOBRADEX 74503378 1897276 Live/Registered |
NOVARTIS AG 1994-03-18 |
 TOBRADEX 73631951 1444831 Dead/Cancelled |
ALCON LABORATORIES, INC. 1986-11-24 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.